期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
10-23DRzs mediated by fluorescent silica nanoparticles inhibit expression of HBV
1
作者 Shi-neng Yan Hong-yuan Zhu +5 位作者 Hui-ying Li Qi-lu Wang Jia-gen Wen Li-qun Kang Jin-feng Zhao Yang-de Zhang 《中国现代医学杂志》 CAS CSCD 北大核心 2011年第3期354-359,共6页
Objective To prepare fluorescent silica nanoparticles(FSNPs) carrying 10-23 deoxyribozymes(10-23DRzs) and to evaluate their inhibitory effect on human hepatitis B virus(HBV).Methods The FSNPs were prepared by microemu... Objective To prepare fluorescent silica nanoparticles(FSNPs) carrying 10-23 deoxyribozymes(10-23DRzs) and to evaluate their inhibitory effect on human hepatitis B virus(HBV).Methods The FSNPs were prepared by microemulsion method and further modified by NaCl.Their diameter and the Zeta potential were tested.The HBV-specific 10-23DRzs were designed according to the sequences of S and C genes of HBV.The 10-23DRzs were connected to FSNPs,which constituted the FSNPs-DNA.The connecting efficiency and the protective effect of nanoparticles on 10-23DRzs were tested by sodium dodecyl sulfate polyacrylamide gel electrophoresis(SDS-PAGE).The HepG2.2.15 cells were transfected by FSNPs-DNA,of which the inhibitory effects on HBsAg and HBeAg were analyzed by enzyme-linked immunosorbent assay(ELISA).Results The nanoparticles were spherical and uniform in size,with a diameter of 220 nm and the surface Zeta potential of +15.2 mV.The combination of DNA and FSNPs effectively protected DNA from nuclease degradation.Transfection of FSNPs-DNA significantly inhibited the expression of HBV S and C genes compared to the liposome control group.Conclusion The FSNPs have been successfully prepared and efficiently connected to HBV-specific 10-23DRzs,which significantly inhibit the expression of HBV S and C genes in cell culture. 展开更多
关键词 10-23drzs FSNPs HBV gene therapy
下载PDF
10-23脱氧核酶对CTX-M-38型超广谱β-内酰胺酶的抑制作用 被引量:1
2
作者 张志坚 郭小兵 +1 位作者 李海霞 张钦宪 《郑州大学学报(医学版)》 CAS 北大核心 2010年第5期740-742,共3页
目的:探讨10-23脱氧核酶(10-23DRz)抑制CTX-M-38型ESBLs的可行性。方法:依据CTX-M-38型ESBLs序列及其mRNA构象特征,设计针对其mRNA结构的10-23DRz脱氧核酸序列及反义核酸序列;采用氯化钙法对10-23DRz及反义核酸进行转化;依据转化菌在平... 目的:探讨10-23脱氧核酶(10-23DRz)抑制CTX-M-38型ESBLs的可行性。方法:依据CTX-M-38型ESBLs序列及其mRNA构象特征,设计针对其mRNA结构的10-23DRz脱氧核酸序列及反义核酸序列;采用氯化钙法对10-23DRz及反义核酸进行转化;依据转化菌在平板上菌落形成状况及菌液吸光度选择10-23DRz应用量;采用K-B法体外药敏试验检测耐药活性。结果:45nmol10-23DRz用量时转化菌菌落形成量及菌液吸光度较为理想。除哌拉西林、头孢噻肟及亚胺培南外,其他抗菌药物10-23DRz组与反义核酸组抑菌环直径间差异有统计学意义(P均<0.001)。结论:10-23DRz可抑制CTX-M-38型ESBLs的表达。 展开更多
关键词 10-23脱氧核酶 CTX-M-38型 超广谱Β-内酰胺酶
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部